The difference between these PD and SCA2 patients seems to be the interruption of the CAG expansion with redundant CAA units in PD, whereas SCA2 patients usually contain a pure CAG tract in the ATXN2 gene [139–141]. Here, ATXN2 is linked to Parkinson disease.